Onconetix Inc (ONCO) support and resistance · P/E 0.0, rev $815.4K
Onconetix Inc (ONCO) is a biotechnology company listed on NASDAQ.
This page maps Onconetix Inc (ONCO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ONCO revenue for 2025-12-31 was $815.4K. Net income was -$14.0M. Revenue was down 67.7% from 2024-12-31 to 2025-12-31. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
ONCO currently screens at market cap $3.7M and trailing P/E 0.0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ONCO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ONCO quote page for the session range and the stock page for the full model.
Not investment advice.